1,2,4-triazole has been researched along with Cancer of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulwahab, HG; Al-Hussain, SA; Al-Qurashi, NT; Farghaly, TA; Muhammad, ZA; Zaki, MEA | 1 |
| Abdel-Aziz, M; Abuo-Rahma, Gel-D; Ali, TF; Beshr, EA | 1 |
2 other study(ies) available for 1,2,4-triazole and Cancer of Kidney
| Article | Year |
|---|---|
Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity.
Topics: Acetophenones; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indoles; Kidney Neoplasms; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Sunitinib; Triazoles; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
New nitric oxide donating 1,2,4-triazole/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activities.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Line, Tumor; Edema; Humans; Kidney Neoplasms; Male; Nitric Oxide; Nitric Oxide Donors; Oximes; Rats; Stomach; Triazoles; Ulcer | 2013 |